Synapse - Works

Results (5712)

Prognostic value of minimal residual disease (MRD) among patients with classical Hodgkin lymphoma undergoing autologous stem cell transplantation

Meeting Abstract

Taranto, E.; Redd, R. A.; Jeter, E.; McHugh, K. M.; Brown, J. R.; Crombie, J. L.; Davids, M. S.; Fisher, D. C.; Freedman, A. S.; Jacobsen, E. D.; more...
Blood (2021)

Fulltext@MSK | Save

Safety and pharmacokinetics of calaspargase pegol in adults with newly diagnosed Philadelphia-negative ALL: A phase 2/3 study

Meeting Abstract

Stock, W.; Park, J. H.; Emadi, A.; Abdul-Hay, M.; Cassaday, R. D.; Pullarkat, V. A.; Webster, J.; Pandya, S. S.; Mogul, M. J.; Shvenke, Y.; more...
Blood (2021)

Fulltext@MSK | Save

Novel genetic subgroups inform on shared pathobiology within adult and pediatric Burkitt lymphoma

Meeting Abstract

Thomas, N.; Dreval, K.; Gerhard, D. S.; Hilton, L. K.; Abramson, J. S.; Bartlett, N. L.; Bethony, J.; Bowen, J.; Bryan, A.; Casper, C.; more...
Blood (2021)

Fulltext@MSK | Save

Timing and immune status after cellular therapies predict response to COVID-19 vaccines

Meeting Abstract

Tamari, R.; Politikos, I.; Knorr, D.; Vardhana, S.; Young, J.; Marcello, L.; Doddi, S.; Devlin, S. M.; Ramanathan, L.; Pessin, M. S.; more...
Blood (2021)

Fulltext@MSK | Save

Siremadlin (HDM201) is well tolerated and demonstrates clinical activity in patients with acute myeloid leukemia who have relapsed after allogeneic stem cell transplantation: A subset analysis of safety and preliminary efficacy

Meeting Abstract

Stein, E. M.; Chromik, J.; Carpio, C.; Mous, R.; Kiladjian, J. J.; Alatrash, G.; Curti, A.; Craddock, C.; Schmid, C.; Zeiser, R.; more...
Blood (2021)

Fulltext@MSK | Save

Safety and efficacy of menin inhibition in patients (Pts) with MLL-rearranged and NPM1 mutant acute leukemia: A phase (Ph) 1, first-in-human study of SNDX-5613 (AUGMENT 101)

Meeting Abstract

Stein, E. M.; Aldoss, I.; DiPersio, J. F.; Stone, R. M.; Arellano, M. L.; Rosen, G.; Meyers, M. L.; Huang, Y. F.; Smith, S.; Bagley, R. G.; more...
Blood (2021)

Fulltext@MSK | Save

Randomized, phase III study of early intervention with venetoclax and obinutuzumab versus delayed therapy with venetoclax and obinutuzumab in newly diagnosed asymptomatic highrisk patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): Evolve CLL/SLL study (SWOG S1925; NCT#04269902)

Meeting Abstract

Stephens, D. M.; Moseley, A.; Hill, B. T.; Pagel, J. M.; Shadman, M.; Fisch, M.; Danilov, A. V.; Ng, D.; Mato, A. R.; Brander, D. M.; more...
Blood (2021)

Fulltext@MSK | Save

Updated survival and response analyses from a phase 1 study of ivosidenib or enasidenib combined with induction and consolidation chemotherapy in patients with newly diagnosed AML with an IDH1 or IDH2 mutation

Meeting Abstract

Stein, E. M.; DiNardo, C. D.; Fathi, A. T.; Mims, A. S.; Savona, M. R.; Stein, A. S.; Stone, R. M.; Winer, E. S.; Seet, C. S.; Döhner, H.; more...
Blood (2021)

Fulltext@MSK | Save

The intestinal microbiota correlates with response and toxicity after CAR T cell therapy in patients with B-cell malignancies

Meeting Abstract

Smith, M.; Dai, A.; Ghilardi, G.; Amelsberg, K.; Devlin, S. M.; Pajarillo, R.; Slingerland, J. B.; Beghi, S.; Herrera, P. S.; Giardina, P. A.; more...
Blood (2021)

Fulltext@MSK | Save

Isogenic MDS-RS patient-derived iPSCs define the mis-spliced transcript repertoire and chromatin landscape of SF3B1-mutant hematopoietic stem/progenitor cells

Meeting Abstract

Asimomitis, G.; Deslauriers, A. G.; Kotini, A. G.; Bernard, E.; Esposito, D.; Olszewska, M.; Spyrou, N.; Ossa, J. A.; Mortera-Blanco, T.; Koche, R.; more...
Blood (2021)

Fulltext@MSK | Save